查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1401002

聚乙二醇化蛋白質市場，按蛋白質類型、按應用、最終用途、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

PEGylated Proteins Market, By Protein Type, By Application, By End-Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 282 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022 年聚乙二醇化蛋白質市場規模為 144.243 億美元，2023 年至 2030 年複合CAGR為 4.7%。

聚乙二醇化蛋白質市場-市場動態

提高生物藥物治療療效和病患體驗的需求推動市場需求

聚乙二醇化具有多種優點，包括增加藥物在體內的循環、降低免疫原性和提高穩定性。這樣可以減少用藥頻率，從而可以提高患者的依從性並減輕慢性病護理的負擔。此外，聚乙二醇化有可能減少副作用和不良反應，使生物製劑對患者更耐受、更安全。因此，製藥公司和學術界正在繼續研究聚乙二醇化作為最佳化當前生物製劑和開發創新療法的技術，其目標是最終改善醫療保健結果。

聚乙二醇化蛋白質市場 - 關鍵見解

根據我們的研究分析師分享的分析，全球聚乙二醇化蛋白質市場預計在預測期內（2023-2030 年）每年將以 4.7% 左右的CAGR成長

由於需要提高生物藥物治療的療效和患者體驗，聚乙二醇化蛋白質產業預計將以顯著的速度成長。

根據蛋白質類型細分，集落刺激因子預計將在 2022 年顯示最大的市場佔有率

根據應用細分，自體免疫疾病是 2022 年領先的蛋白質類型

按地區分類，北美是 2022 年的主要收入來源

聚乙二醇化蛋白質市場區隔分析：

全球聚乙二醇化蛋白質市場根據蛋白質類型、應用、最終用途和地區進行細分。

根據蛋白質類型，市場分為四類：集落刺激因子、干擾素、促紅血球生成素和其他。集落刺激因子主導市場。聚乙二醇化蛋白質，尤其是聚乙二醇化集落刺激因子，由於其在各種醫學應用中的用途而受到很高的需求。集落刺激因子可增加血球的產生，通常經過聚乙二醇化，以提高其對癌症、貧血和免疫缺陷等疾病的治療效果。

依應用市場分為三類：癌症、自體免疫疾病、肝炎、多發性硬化症、血友病、胃腸道疾病和其他。自體免疫疾病領域在市場中佔據主導地位，並可能在預測期內保持其主導地位。聚乙二醇化蛋白在自體免疫疾病的應用需求量很大。這些生物製劑可以透過使用聚乙二醇（PEG）來改變自體免疫相關蛋白來調節免疫反應和降低炎症，從而延長半衰期並提高治療類風濕性關節炎、多發性硬化症和狼瘡等疾病的功效。

聚乙二醇化蛋白質市場 - 地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲地區。這些區域根據開展業務的國家進一步分類。有幾個變數影響北美聚乙二醇化蛋白質的市場。該地區擁有完善的製藥和生物技術部門，致力於創新生物藥物的開發和商業化。此外，癌症、自體免疫疾病和血液疾病等慢性疾病的發生率不斷增加，也增加了對客製化生物療法的需求。此外，北美的監管框架促進了創新藥物配方的創新和開發，例如聚乙二醇化蛋白，可提高治療效果和患者依從性。最後，該地區強大的醫療基礎設施和尖端療法的可用性使其成為聚乙二醇化蛋白質療法的良好市場，推動了該領域的持續研究和投資。

聚乙二醇化蛋白質市場-競爭格局：

聚乙二醇化蛋白質的競爭環境是動態且多元的。羅氏、安進和諾和諾德等領先的製藥和生物技術公司在單株抗體和細胞因子等聚乙二醇化生物製劑的開發上進行了大量投資。然而，該領域也有創意新創公司和專業生物技術公司，例如僅專注於聚乙二醇化技術的 Nektar Therapeutics。這種多樣性鼓勵創新和競爭力，推動藥物傳遞的突破並提高生物製劑的治療效果。隨著對重點和持久生物藥物的需求不斷發展，競爭環境不斷變化，重點是生產更有效和對患者友好的聚乙二醇化蛋白療法。

目錄

第 1 章：聚乙二醇化蛋白質市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按蛋白質類型分類的聚乙二醇化蛋白質市場片段
    • 聚乙二醇化蛋白質市場片段（依應用）
    • 依最終用途分類的聚乙二醇化蛋白質市場片段
    • 按國家/地區分類的聚乙二醇化蛋白質市場片段
    • 按地區分類的聚乙二醇化蛋白質市場片段
  • 競爭洞察

第 3 章：聚乙二醇化蛋白質主要市場趨勢

  • 聚乙二醇化蛋白質市場促進因素
    • 市場促進因素的影響分析
  • 聚乙二醇化蛋白質市場限制
    • 市場限制影響分析
  • 聚乙二醇化蛋白質市場機會
  • 聚乙二醇化蛋白質市場未來趨勢

第 4 章：聚乙二醇化蛋白質產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：聚乙二醇化蛋白質市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：聚乙二醇化蛋白質市場格局

  • 2022 年聚乙二醇化蛋白質市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：聚乙二醇化蛋白質市場 - 依蛋白質類型

  • 概述
    • 按蛋白質類型分類的細分市場佔有率分析
    • 集落刺激因子
    • 干擾素
    • 促紅血球生成素
    • 其他

第 8 章：聚乙二醇化蛋白質市場 -按應用

  • 概述
    • 按應用的細分市場佔有率分析
    • 癌症
    • 自體免疫疾病
    • 肝炎
    • 多發性硬化症
    • 血友病
    • 胃腸道疾病
    • 其他

第 9 章：聚乙二醇化蛋白質市場 - 按最終用途

  • 概述
    • 按最終用途分類的細分市場佔有率分析
    • 製藥與生物技術公司
    • 合約研究組織
    • 學術及研究機構

第 10 章：聚乙二醇化蛋白質市場 - 依地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 聚乙二醇化蛋白質北美主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按蛋白質類型）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按最終用途）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 聚乙二醇化蛋白質歐洲主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按蛋白質類型）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按最終用途）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 聚乙二醇化蛋白質亞太地區主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模和預測（按蛋白質類型）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模和預測（按最終用途）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲聚乙二醇化蛋白質主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按蛋白質類型）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模和預測（按最終用途）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲的聚乙二醇化蛋白質主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按蛋白質類型）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模和預測（按最終用途）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 聚乙二醇化蛋白質產業

  • 競爭儀表板
  • 公司簡介
    • Biogen Inc
    • Pfizer Inc
    • UCB SA
    • Leadiant Biosciences, Inc.
    • Amgen Inc.
    • Thermo Fisher Scientific Inc.
    • Horizon Therapeutics Plc.
    • Novo Nordisk A/S
    • F. Hoffmann-La Roche AG
    • Bayer AG
    • BioMarin
    • RedHill Biopharma Ltd.
    • Profacgen
    • Creative PEGworks
    • NOF America Corp.
    • Aurigene Pharmaceutical Services Ltd.
    • Laysan Bio, Inc.

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV1966

REPORT HIGHLIGHT

PEGylated Proteins Market size was valued at USD 14,424.3 Million in 2022, expanding at a CAGR of 4.7 % from 2023 to 2030.

Therapeutic biologics or molecules that were chemically changed by the addition of polyethylene glycol (PEG) chains are referred to as PEGylated proteins. This change is intended to improve the biologic's pharmacokinetic features, such as enhanced stability, longer bloodstream circulation duration, and decreased immunogenicity. PEGylation increases medication bioavailability, allowing for less frequent dosage and perhaps decreasing adverse effects. This technology is frequently utilized in the pharmaceutical industry to enhance the therapeutic profile of different biologics, such as proteins and peptides, making them more successful in the treatment of a variety of medical disorders such as cancer, autoimmune diseases, and hemophilia.

PEGylated Proteins Market- Market Dynamics

The need to enhance the therapeutic efficacy and patient experience in biologic drug treatments propel market demand

PEGylation has various benefits, including increased medication circulation throughout the body, less immunogenicity, and greater stability. This enables less frequent dosage, which may improve patient compliance and reduce the burden of chronic illness care. Furthermore, PEGylation has the potential to reduce side effects and adverse responses, making biologics more bearable and safer for patients. As a consequence, pharmaceutical firms and academics are continuing to investigate PEGylation as a technique for optimizing current biologics and developing innovative therapies, with the goal of eventually improving healthcare outcomes.

PEGylated Proteins Market- Key Insights

As per the analysis shared by our research analyst, the global PEGylated Proteins market is estimated to grow annually at a CAGR of around 4.7% over the forecast period (2023-2030)

The PEGylated Proteins industry is projected to grow at a significant rate due to the need to enhance the therapeutic efficacy and patient experience in biologic drug treatments.

Based on Protein Type segmentation, Colony-stimulating Factors was predicted to show maximum market share in the year 2022

Based on Application segmentation, Autoimmune Diseases was the leading Protein Type in 2022

On the basis of region, North America was the leading revenue generator in 2022

PEGylated Proteins Market- Segmentation Analysis:

The Global PEGylated Proteins Market is segmented on the basis of Protein Type, Application, End-Use, and Region.

The market is divided into four categories based on Protein Type: Colony-stimulating Factors, Interferons, Erythropoietin, and Others. The Colony-stimulating Factors dominates the market. PEGylated proteins, especially PEGylated colony-stimulating factors, are in high demand due to their usage in a variety of medicinal applications. Colony-stimulating factors, which increase the creation of blood cells, are often PEGylated to improve their therapeutic effectiveness in illnesses such as cancer, anaemia, and immunodeficiency disorders.

The market is divided into three categories based on Application: Cancer, Autoimmune Diseases, Hepatitis, Multiple Sclerosis, Hemophilia, Gastrointestinal Disorders, and Others. The Autoimmune Diseases sector dominates the market and is likely to maintain its dominance during the forecast period. PEGylated proteins are in high demand for use in autoimmune disorders. These biologics may provide prolonged half-lives and enhanced efficacy in treating illnesses such as rheumatoid arthritis, multiple sclerosis, and lupus by modulating immune responses and lowering inflammation by altering autoimmune-related proteins using polyethylene glycol (PEG).

PEGylated Proteins Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. Several variables influence the market for PEGylated proteins in North America. The area boasts a well-established pharmaceutical and biotechnology sector devoted to the development and commercialization of innovative biologic medicines. Additionally, the increasing frequency of chronic illnesses such as cancer, autoimmune disorders, and blood disorders has boosted the need for tailored biologic therapies. Furthermore, the regulatory framework in North America fosters innovation and the development of innovative medicine formulations, such as PEGylated proteins, which enhance treatment results and patient compliance. Finally, the region's strong healthcare infrastructure and availability of cutting-edge therapies make it a good market for PEGylated protein therapeutics, fueling continuous research and investment in this sector.

PEGylated Proteins Market- Competitive Landscape:

The competitive environment for PEGylated proteins is dynamic and varied. Leading pharmaceutical and biotechnology firms such as Roche, Amgen, and Novo Nordisk have made significant investments in the development of PEGylated biologics such as monoclonal antibodies and cytokines. However, there are also creative startups and specialized biotech corporations in the sector, such as Nektar Therapeutics, which focuses only on PEGylation technology. This variety encourages innovation and competitiveness, pushing for breakthroughs in drug delivery and increasing biologics' therapeutic profile. The competitive environment continues to change as the need for focused and long-lasting biologic medicines develops, with an emphasis on producing more effective and patient-friendly PEGylated protein therapeutics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PEGYLATED PROTEINS MARKET KEY PLAYERS

  • Biogen Inc
  • Pfizer Inc
  • UCB S.A.
  • Leadiant Biosciences, Inc.
  • Amgen Inc.
  • Thermo Fisher Scientific Inc.
  • Horizon Therapeutics Plc.
  • Novo Nordisk A/S
  • F. Hoffmann-La Roche AG
  • Bayer AG
  • BioMarin
  • RedHill Biopharma Ltd.
  • Profacgen
  • Creative PEGworks
  • NOF America Corp.
  • Aurigene Pharmaceutical Services Ltd.
  • Laysan Bio, Inc.

GLOBAL PEGYLATED PROTEINS MARKET, BY PROTEIN TYPE

  • Colony-stimulating Factors
  • Interferons
  • Erythropoietin
  • Others

GLOBAL PEGYLATED PROTEINS MARKET, BY APPLICATION

  • Cancer
  • Autoimmune Diseases
  • Hepatitis
  • Multiple Sclerosis
  • Hemophilia
  • Gastrointestinal Disorders
  • Others

GLOBAL PEGYLATED PROTEINS MARKET, BY END-USE

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Academic & Research Institutes

GLOBAL PEGYLATED PROTEINS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. PEGylated Proteins Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. PEGylated Proteins Market Snippet by Protein Type
    • 2.1.2. PEGylated Proteins Market Snippet by Application
    • 2.1.3. PEGylated Proteins Market Snippet by End-Use
    • 2.1.4. PEGylated Proteins Market Snippet by Country
    • 2.1.5. PEGylated Proteins Market Snippet by Region
  • 2.2. Competitive Insights

3. PEGylated Proteins Key Market Trends

  • 3.1. PEGylated Proteins Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. PEGylated Proteins Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. PEGylated Proteins Market Opportunities
  • 3.4. PEGylated Proteins Market Future Trends

4. PEGylated Proteins Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. PEGylated Proteins Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. PEGylated Proteins Market Landscape

  • 6.1. PEGylated Proteins Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. PEGylated Proteins Market - By Protein Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Protein Type, 2022 & 2030 (%)
    • 7.1.2. Colony-stimulating Factors
    • 7.1.3. Interferons
    • 7.1.4. Erythropoietin
    • 7.1.5. Others

8. PEGylated Proteins Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Cancer
    • 8.1.3. Autoimmune Diseases
    • 8.1.4. Hepatitis
    • 8.1.5. Multiple Sclerosis
    • 8.1.6. Hemophilia
    • 8.1.7. Gastrointestinal Disorders
    • 8.1.8. Others

9. PEGylated Proteins Market - By End-Use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-Use, 2022 & 2030 (%)
    • 9.1.2. Pharmaceutical & Biotechnology Companies
    • 9.1.3. Contract Research Organizations
    • 9.1.4. Academic & Research Institutes

10. PEGylated Proteins Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. PEGylated Proteins Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. PEGylated Proteins Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. PEGylated Proteins Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. PEGylated Proteins Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. PEGylated Proteins Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- PEGylated Proteins Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Biogen Inc
    • 11.2.2. Pfizer Inc
    • 11.2.3. UCB S.A.
    • 11.2.4. Leadiant Biosciences, Inc.
    • 11.2.5. Amgen Inc.
    • 11.2.6. Thermo Fisher Scientific Inc.
    • 11.2.7. Horizon Therapeutics Plc.
    • 11.2.8. Novo Nordisk A/S
    • 11.2.9. F. Hoffmann-La Roche AG
    • 11.2.10. Bayer AG
    • 11.2.11. BioMarin
    • 11.2.12. RedHill Biopharma Ltd.
    • 11.2.13. Profacgen
    • 11.2.14. Creative PEGworks
    • 11.2.15. NOF America Corp.
    • 11.2.16. Aurigene Pharmaceutical Services Ltd.
    • 11.2.17. Laysan Bio, Inc.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data Applications
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE PEGylated Proteins Market: Protein Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Protein Type
  • TABLE Global PEGylated Proteins Market, by Protein Type 2018-2030 (USD Million)
  • TABLE PEGylated Proteins Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global PEGylated Proteins Market, by Application 2018-2030 (USD Million)
  • TABLE PEGylated Proteins Market: End-Use Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-Use
  • TABLE Global PEGylated Proteins Market, by End-Use 2018-2030 (USD Million)
  • TABLE PEGylated Proteins Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global PEGylated Proteins Market, by Region 2018-2030 (USD Million)
  • TABLE North America PEGylated Proteins Market, by Country, 2018-2030 (USD Million)
  • TABLE North America PEGylated Proteins Market, by Protein Type, 2018-2030 (USD Million)
  • TABLE North America PEGylated Proteins Market, by Application, 2018-2030 (USD Million)
  • TABLE North America PEGylated Proteins Market, by End-Use, 2018-2030 (USD Million)
  • TABLE Europe PEGylated Proteins Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe PEGylated Proteins Market, by Protein Type, 2018-2030 (USD Million)
  • TABLE Europe PEGylated Proteins Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe PEGylated Proteins Market, by End-Use, 2018-2030 (USD Million)
  • TABLE Asia Pacific PEGylated Proteins Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific PEGylated Proteins Market, by Protein Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific PEGylated Proteins Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific PEGylated Proteins Market, by End-Use, 2018-2030 (USD Million)
  • TABLE Latin America PEGylated Proteins Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America PEGylated Proteins Market, by Protein Type, 2018-2030 (USD Million)
  • TABLE Latin America PEGylated Proteins Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America PEGylated Proteins Market, by End-Use, 2018-2030 (USD Million)
  • TABLE Middle East and Africa PEGylated Proteins Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa PEGylated Proteins Market, by Protein Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa PEGylated Proteins Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa PEGylated Proteins Market, by End-Use, 2018-2030 (USD Million)

List of Figures

  • FIGURE PEGylated Proteins Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Protein Type segment market share analysis, 2022 & 2030
  • FIGURE Protein Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End-Use segment market share analysis, 2022 & 2030
  • FIGURE End-Use segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America PEGylated Proteins Market share and leading players, 2022
  • FIGURE Europe PEGylated Proteins Market share and leading players, 2022
  • FIGURE Asia Pacific PEGylated Proteins Market share and leading players, 2022
  • FIGURE Latin America PEGylated Proteins Market share and leading players, 2022
  • FIGURE Middle East and Africa PEGylated Proteins Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe PEGylated Proteins Market share analysis by country, 2022
  • FIGURE Germany PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific PEGylated Proteins Market share analysis by country, 2022
  • FIGURE India PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America PEGylated Proteins Market share analysis by country, 2022
  • FIGURE Brazil PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa PEGylated Proteins Market share analysis by country, 2022
  • FIGURE Saudi Arabia PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)